Filter
2268
Filtered Results: 2268
Text search:
randomized
Featured
Recommendations
226
New Publications
387
Language
Document type
No document type
1182
Guidelines
464
Studies & Reports
398
Manuals
96
Fact sheets
49
Strategic & Response Plan
29
Training Material
26
Situation Updates
11
Infographics
7
Resource Platforms
5
Brochures
1
Countries / Regions
Global
94
India
93
South Africa
48
Kenya
43
Western and Central Europe
36
Russia
35
Brazil
34
Africa
29
Latin America and the Carribbean
28
Malawi
27
Uganda
26
Nepal
22
Ethiopia
22
Ukraine
20
Indonesia
19
Tanzania
18
Sierra Leone
17
Philippines
17
Eastern Europe
17
Zambia
17
Nigeria
16
Zimbabwe
16
Germany
15
Mozambique
14
Rwanda
13
Bangladesh
12
Colombia
11
Asia
11
Liberia
11
Ghana
10
Senegal
10
Burkina Faso
10
West and Central Africa
10
Argentina
10
South Sudan
10
Syria
9
Congo, Democratic Republic of
9
East and Southern Africa
9
Paraguay
8
Angola
8
Cameroon
7
USA
7
Middle East and North Africa
7
South–East Asia Region
7
Lesotho
6
Chile
6
Peru
6
Guinea
6
Eastern Europe and Central Asia
6
Namibia
6
Haiti
5
Bolivia
5
Yemen
5
Myanmar / Burma
5
China
4
Cambodia
4
Guinea-Bissau
4
Spain
4
Ecuador
4
Eswatini/ Swaziland
4
Thailand
3
Laos
3
Venezuela
3
Jordan
3
North America
3
Sudan
3
Iraq
3
Somalia
3
Benin
2
Kyrgyzstan
2
Burundi
2
Western Pacific Region
2
United Kingdom
2
Portugal
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Sri Lanka
2
Central African Republic
2
Mali
2
North Macedonia
1
Tajikistan
1
El Salvador
1
Turkey
1
Kazakhstan
1
Canada
1
Singapore
1
Estonia
1
Afghanistan
1
Qatar
1
Armenia
1
Belgium
1
France
1
Belarus
1
Israel
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Moldova
1
Georgia
1
Botswana
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
549
Clinical Guidelines
340
Women & Child Health
168
Public Health
156
Key Resources
47
Capacity Building
21
Pharmacy & Technologies
10
Toolboxes
Mental Health
376
COVID-19
261
HIV
260
TB
161
NCDs
91
NTDs
78
Caregiver
77
Ebola
47
Planetary Health
40
Rapid Response
39
AMR
38
Disability
36
Pharmacy
26
Refugee
25
Conflict
24
Cholera
17
Global Health Education
16
Polio
9
Natural Hazards
7
Zika
7
Social Ethics
6
Health Financing Toolbox
5
Specific Hazards
1
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b158 (Published 05 February 2009)
Cite this as: BMJ 2009;338:b158
Correspondence to: A Burns alistair.burns@manchester.ac.uk
Q9: For carers of people with dementia, do interventions (psychoeducational, cognitive-behavioural therapy counseling/case management, general support, training of caregivers, multi-component interventions and miscellaneous interventions) when compared to placebo/comparator, produce benefits/harm in...
Q5: For people with dementia, which cognitive/psychosocial interventions (such as cognitive stimulation, cognitive rehabilitation, reality orientation, reminiscence therapy) when compared to placebo/comparator produce benefits/harm in the specified outcomes?
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
Q8. Should Anti-Epileptic Drug (AED) treatment be started after first unprovoked seizure in non-specialist health settings?
SCOPING QUESTION: In adults with acute convulsive seizures, where intravenous access is available, which first-line anti- epileptic medication should be used to abort seizures when compared to comparator?
[Updated 2015]
Scoping Question: In adults with acute convulsive seizures in first-level care or in the community (when no IV access is available), which antiepileptic medications produce benefits and/or harm when compared to comparator?
В методических рекомендациях представлены современные подходы к терапии поведенческих и психотических расстройств у пациентов с болезнью Альцгеймера. Ведение т...
Q1: What are the effective maternal mental health interventions to prevent developmental problems in early infancy?
SCOPING QUESTION: Which psychosocial interventions are effective in the management of cannabis dependence?
SCOPING QUESTION:Which psychosocial interventions are effective in the treatment of psychostimulant dependence for adults and young people?
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder
Accessed: 14.03.2019
SCOPING QUESTION: In the management of prescription opioid dependence, does supervised dosing with a long-acting opioid medication result in less opioid use and related harms than non-prescription, detoxification or usual care?
Petersen et al. Int J Ment Health Syst (2016) 10:30 DOI 10.1186/s13033-016-0060-z
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999
Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
